These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 3079078

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Randomized clinical trial of cyclosporine or donor specific transfusions in high risk living-related donor transplantation.
    Bordes-Aznar J, Odor A, Dib-Kuri A, Gabilondo F, Kasep J, Peña JC, Herrera-Acosta J, Chávez-Peón F.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2276-7. PubMed ID: 3079080
    [No Abstract] [Full Text] [Related]

  • 23. Association of anti-Fab and anti-IgG antibodies with high kidney transplant survival.
    Chia D, Horimi T, Terasaki PI, Hermes M.
    Transplant Proc; 1982 Jun; 14(2):322-4. PubMed ID: 7051474
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Skin test reactivity and lymphocyte subsets in cyclosporine versus azathioprine-treated renal transplant recipients.
    Pomer S, Daniel V, Dreikorn K, Röhl L.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1568-9. PubMed ID: 3079026
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Transplant-induced donor-specific antibodies and graft outcome.
    Martin S, Dyer PA, Mallick NP, Gokal R, Johnson RW.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):899-90. PubMed ID: 3274886
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Graft survival with high levels of cytotoxic antibodies.
    Feduska NJ, Amend WJ, Vincenti F, Perkins HA, Opelz G, Terasaki PI, Iwaki Y, Duca R, Dodge D, Salvatierra O.
    Transplant Proc; 1981 Mar; 13(1 Pt 1):73-80. PubMed ID: 7022910
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prophylactic use of an antilymphocyte monoclonal antibody following renal transplantation: a randomized controlled trial.
    Friend PJ, Calne RY, Hale G, Waldmann H, Evans DB, Rolles K, Thiru S, Gore S.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1898-900. PubMed ID: 3079058
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Donor-specific transfusion with and without cyclosporine A--a controlled clinical trial.
    Sells RA, Hillis A, Bone MJ, Evans P, Evans CM, Scott MM.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):270-3. PubMed ID: 3291255
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy.
    Milgrom M, Kyriakides GK, Esquenazi V, Olson L, Miller J.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1873. PubMed ID: 3274444
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.